Publications and more: We are happy to share our expertise with you!

Here you will find publications and scientific articles by Arud employees as first or co-authors.

Our flyers are available for download from our webshop.

Articles & Publications

July 2017 | International Journal of Drug Policy | Hepatitis C

Research priorities to achieve universal access to hepatitis C prevention, management and direct-acting antiviral treatment among people who inject drugs.

Grebely, J., et al.

Link

June 2017 | International Journal of Drug Policy | Hepatitis C

Efficacy of response-guided directly observed pegylated interferon and self-administered ribavirin for people who inject drugs with hepatitis C virus genotype 2/3 infection: The ACTIVATE study.

Grebely, J., et al.

Link

June 2017 | BMC Infectious Diseases | Hepatitis C

Adherence to response-guided pegylated interferon and ribavirin for people who inject drugs with hepatitis C virus genotype 2/3 infection: the ACTIVATE study.

Cunningham, E. B., et al.

Link

May 2017 | Infectious Diseases and Therapy | Hepatitis C

Chronic Hepatitis C Treatment in Patients with Drug Injection History: Findings of the INTEGRATE Prospective, Observational Study.

Robaeys, G., et al.

Link

May 2017 | Journal of Clinical Virology | Hepatitis C

Hepatitis C virus core antigen: A simplified treatment monitoring tool, including for post-treatment relapse

Lamoury, F. M. J., et al.

Link

Back

3

Next

Show more articles

Arud Research Publication Series

Nr. 6

Subjektive Lebensqualität opioidabhängiger Menschen in einer substitutionsgestützten Behandlung

Magdalena Dampz, Luis Falcato

Download

Nr. 5

Behandlungszufriedenheit der Patientinnen und Patienten der Poliklinik Zokl1

Susan Dober Spielmann, Luis Falcato, Daniel Meili

Download

Nr. 4

Kokainkonsumierende in der Methadonbehandlung

Susan Dober Spielmann, Anja Dobler-Mikola, Daniel Meili

Download

Nr. 3

Kontinuität beim Bezug des Substitutionsmittels in einer Methadonbehandlung

Susan Dober Spielmann, Anja Dobler-Mikola, Daniel Meili

Download

Nr. 2

Patientenspezifische Risikofaktoren für Drop-Outs in der Methadonbehandlung

Susan Dober Spielmann, Anja Dobler-Mikola , Daniel Meili

Download

Back

1

2

3

4

Next

Show more reports

Publications

Articles & Publications

Research priorities to achieve universal access to hepatitis C prevention, management and direct-acting antiviral treatment among people who inject drugs.

Efficacy of response-guided directly observed pegylated interferon and self-administered ribavirin for people who inject drugs with hepatitis C virus genotype 2/3 infection: The ACTIVATE study.

Adherence to response-guided pegylated interferon and ribavirin for people who inject drugs with hepatitis C virus genotype 2/3 infection: the ACTIVATE study.

Chronic Hepatitis C Treatment in Patients with Drug Injection History: Findings of the INTEGRATE Prospective, Observational Study.

Hepatitis C virus core antigen: A simplified treatment monitoring tool, including for post-treatment relapse

Arud Research Publication Series

Subjektive Lebensqualität opioidabhängiger Menschen in einer substitutionsgestützten Behandlung

Behandlungszufriedenheit der Patientinnen und Patienten der Poliklinik Zokl1

Kokainkonsumierende in der Methadonbehandlung

Kontinuität beim Bezug des Substitutionsmittels in einer Methadonbehandlung

Patientenspezifische Risikofaktoren für Drop-Outs in der Methadonbehandlung

Fact Sheets

Annual Reports & Financial Statements

2016

2016

2015

2015

2014

2013